Ovid Therapeutics Inc. (OVID)
NASDAQ: OVID · Real-Time Price · USD
0.3097
-0.0022 (-0.71%)
At close: Apr 1, 2025, 4:00 PM
0.3093
-0.0004 (-0.15%)
After-hours: Apr 1, 2025, 4:16 PM EDT
Ovid Therapeutics Stock Forecast
OVID's stock price has decreased by -89.77% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 6 analysts with 12-month price forecasts for Ovid Therapeutics stock have an average target of 3.03, with a low estimate of 1.20 and a high estimate of 4.00. The average target predicts an increase of 878.37% from the current stock price of 0.31.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Ovid Therapeutics stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 1 | 1 | 1 | 2 | 2 | 2 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BTIG | BTIG | Strong Buy Maintains $5 → $4 | Strong Buy | Maintains | $5 → $4 | +1,191.57% | Mar 24, 2025 |
| Wedbush | Wedbush | Buy Maintains $4 → $3 | Buy | Maintains | $4 → $3 | +868.68% | Mar 12, 2025 |
| Oppenheimer | Oppenheimer | Hold → Buy Upgrades $4 | Hold → Buy | Upgrades | $4 | +1,191.57% | Jan 29, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $3 | Strong Buy | Reiterates | $3 | +868.68% | Dec 4, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $3 | Strong Buy | Reiterates | $3 | +868.68% | Sep 30, 2024 |
Financial Forecast
Revenue This Year
275.40K
from 566.00K
Decreased by -51.34%
Revenue Next Year
374.85K
from 275.40K
Increased by 36.11%
EPS This Year
-0.60
from -0.37
EPS Next Year
-0.61
from -0.60
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 598,500 | 598,500 | 367,500 | ||
| Avg | 275,400 | 374,850 | 178,500 | ||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 5.7% | 117.3% | -2.0% | ||
| Avg | -51.3% | 36.1% | -52.4% | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -0.53 | -0.56 | -0.63 |
| Avg | -0.60 | -0.61 | -0.81 |
| Low | -0.71 | -0.73 | -0.96 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.